(Q73793888)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

M Salden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T A Splinter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H A Peters

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M P Look

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Timmermans

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J P van Meerbeeck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J A Foekens

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

327-332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

The urokinase-type plasminogen activator system in cancer metastasis: a review

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Biology and biochemistry of proteinases in tumor invasion.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Immunohistochemical Study of Tumor Cell-associated Plasminogen Activators and Plasminogen Activator Inhibitors in Lung Carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008312801800

7 January 2021

Identifiers

DOI

10.1023/A:1008312801800

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10811500%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference